Table 1.

Analysis of tocopherols and their metabolites in the serum of ACI rats

Treatment	α-T (μM)	δ-T (μM)	γ-T (μM)	α-CEHC (μM)	δ-CEHC (μM)	γ-CEHC (μM)
Negative control	28.4 ± 3.7	0.08 ± 0.03	0.30 ± 0.10	0.2 ± 0.1	0.7 ± 0.1	0.5 ± 0.1
E2 control	34.8 ± 8.0	0.05 ± 0.02	0.30 ± 0.10	0.3 ± 0.0	0.9 ± 0.2	1.3 ± 0.4
E2 + 0.2% α-T	74.5 ± 8.7**	0.06 ± 0.01	0.02 ± 0.00	24.6 ± 13.8**	1.2 ± 0.5	2.6 ± 1.4
E2 + 0.2% δ-T	27.9 ± 0.6	4.06 ± 0.50 ***	0.30 ± 0.01	0.3 ± 0.1	184.1 ± 20.7***	2.7 ± 0.7
E2 + 0.2% γ-T	27.0 ± 1.3	0.10 ± 0.01 ***	23.60 ± 2.80***	0.3 ± 0.1	1.5 ± 0.2	133.3 ± 13.9***
E2 + 0.2% γ-TmT	34.3 ± 1.7	1.50 ± 0.40 **	4.80 ± 1.00**	0.9 ± 0.2*	55.4 ± 7.9***	47.3 ± 11.9**

The effects of α-, δ-, γ-T and γ-TmT supplementation on the levels of α-, δ- and γ-T and their short chain CEHC metabolite in the serum (μMol/l) of ACI rats were analyzed at 30 weeks. P-values are compared to the E2 control. Statistical significance

^*P < 0.05,

^**P < 0.01,

^***P < 0.001.